CY2466B1 - Phenyl dihydrobenzofuranes. - Google Patents

Phenyl dihydrobenzofuranes.

Info

Publication number
CY2466B1
CY2466B1 CY0400056A CY0400056A CY2466B1 CY 2466 B1 CY2466 B1 CY 2466B1 CY 0400056 A CY0400056 A CY 0400056A CY 0400056 A CY0400056 A CY 0400056A CY 2466 B1 CY2466 B1 CY 2466B1
Authority
CY
Cyprus
Prior art keywords
pct
date nov
sec
dihydrobenzofuranes
phenyl
Prior art date
Application number
CY0400056A
Other languages
English (en)
Inventor
Hermann Amschler
Thomas Baer
Beate Gutterer
Dieter Flockerzi
Thomas Martin
Ulrich Thibaut
Armin Hatzelmann
Rolf Beume
Hildegard Boss
Dietrich Haefner
Hans-Peter Kley
Wolf-Ruediger Ulrich
Original Assignee
Byk Gulden Lomberg Chem Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chem Fab filed Critical Byk Gulden Lomberg Chem Fab
Publication of CY2466B1 publication Critical patent/CY2466B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/94—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom spiro-condensed with carbocyclic rings or ring systems, e.g. griseofulvins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/86—Benzo [b] furans; Hydrogenated benzo [b] furans with an oxygen atom directly attached in position 7

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Furan Compounds (AREA)
CY0400056A 1995-05-18 2004-07-02 Phenyl dihydrobenzofuranes. CY2466B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH147295 1995-05-18

Publications (1)

Publication Number Publication Date
CY2466B1 true CY2466B1 (en) 2005-06-03

Family

ID=4211283

Family Applications (1)

Application Number Title Priority Date Filing Date
CY0400056A CY2466B1 (en) 1995-05-18 2004-07-02 Phenyl dihydrobenzofuranes.

Country Status (12)

Country Link
US (1) US5902824A (xx)
EP (1) EP0828728B1 (xx)
JP (1) JPH11505236A (xx)
AT (1) ATE231501T1 (xx)
AU (1) AU698028B2 (xx)
CA (1) CA2221357A1 (xx)
CY (1) CY2466B1 (xx)
DE (1) DE59610077D1 (xx)
DK (1) DK0828728T3 (xx)
ES (1) ES2191754T3 (xx)
PT (1) PT828728E (xx)
WO (1) WO1996036625A1 (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
CN1163493C (zh) * 1995-05-19 2004-08-25 协和发酵工业株式会社 含氧杂环化合物
EP0934307B1 (en) 1996-06-19 2011-04-27 Aventis Pharma Limited Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
DE69719358T2 (de) * 1996-11-20 2003-12-24 Altana Pharma Ag Substituierte dihydrobenzofurane als pde-hemmstoffe
US6247016B1 (en) * 1998-08-24 2001-06-12 Lucent Technologies, Inc. Decision tree classifier with integrated building and pruning phases
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
NZ517166A (en) 1999-08-21 2004-01-30 Altana Pharma Ag Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists
CA2404226A1 (en) * 2000-03-23 2001-09-27 Takeda Chemical Industries, Ltd. Furoisoquinoline derivatives, process for producing the same and use thereof
MXPA03001958A (es) * 2000-09-06 2003-06-24 Tanabe Seiyaku Co Preparaciones para administrar oral.
ATE472319T1 (de) * 2001-02-15 2010-07-15 Mitsubishi Tanabe Pharma Corp Tabletten, die in der mundhöhle schnell zerfallen
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
SE0202133D0 (sv) 2002-07-08 2002-07-08 Astrazeneca Ab Novel compounds
SE0302755D0 (sv) * 2003-10-17 2003-10-17 Astrazeneca Ab Novel compounds
SE0303090D0 (sv) 2003-11-20 2003-11-20 Astrazeneca Ab Novel compounds
SE0303541D0 (sv) 2003-12-22 2003-12-22 Astrazeneca Ab New compounds
PE20070182A1 (es) * 2005-07-29 2007-03-06 Wyeth Corp Derivados cianopirrol-fenil amida como moduladores del receptor de progesterona
PE20070341A1 (es) * 2005-07-29 2007-04-13 Wyeth Corp Derivados de pirrol como moduladores del receptor de progesterona
EP2258357A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (en) 2012-01-10 2014-11-26 President and Fellows of Harvard College Beta-cell replication promoting compounds and methods of their use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9301943A (es) * 1992-04-02 1994-08-31 Smithkline Beecham Corp Compuestos.
US5602173A (en) * 1992-04-02 1997-02-11 Smithkline Beecham Corporation Compounds useful for treating allergic and inflammatory diseases
US5605923A (en) * 1992-04-02 1997-02-25 Smithkline Beecham Corporation Compounds useful for treating inflammatory diseases and inhibiting production of tumor necrosis factor
WO1994002465A1 (en) * 1992-07-28 1994-02-03 Rhone-Poulenc Rorer Limited INHIBITORS OF c-AMP PHOSPHODIESTERASE AND TNF
CN1163493C (zh) * 1995-05-19 2004-08-25 协和发酵工业株式会社 含氧杂环化合物

Also Published As

Publication number Publication date
PT828728E (pt) 2003-06-30
WO1996036625A1 (de) 1996-11-21
EP0828728B1 (de) 2003-01-22
EP0828728A1 (de) 1998-03-18
AU698028B2 (en) 1998-10-22
CA2221357A1 (en) 1996-11-21
ATE231501T1 (de) 2003-02-15
DE59610077D1 (de) 2003-02-27
ES2191754T3 (es) 2003-09-16
AU5895496A (en) 1996-11-29
US5902824A (en) 1999-05-11
DK0828728T3 (da) 2003-05-19
JPH11505236A (ja) 1999-05-18

Similar Documents

Publication Publication Date Title
CY2466B1 (en) Phenyl dihydrobenzofuranes.
CY2462B1 (en) Cyclohexyl dihydrobenzofuranes.
MY132106A (en) New pyridazin-3(2h)-one derivatives
MXPA04012965A (es) Inhibidores virales.
TNSN03144A1 (en) Pyrrolopyrimidines as protein kinase inhibitors
RS101304A (sr) Indolni, azaindolni i srodni heterociklični 4-alkenil piperidinski amidi
MXPA04000577A (es) Derivados de dolastatina 10.
DE602004007239D1 (de) 4-AMINOTHIENOÄ2,3-dÜ PYRIMIDIN -6-CARBONITRIL-DERIVATIVE ZUR VERWENDUNG ALS PDE7 INHIBITOREN
BG103969A (en) C-4"-substituted macrolide derivatives
SG147450A1 (en) Sustained release pharmaceutical compositions comprising aplindore and derivatives thereof
AP2003002929A0 (en) Pyrrolopyrimidines as protein kinase inhibitors
TW200514772A (en) Novel tetrahydropyridine derivatives
EA200000355A2 (ru) Промышленные изделия
AU2003300911A1 (en) Heterocyclic compounds as ccr5 antagonists
YU87202A (sh) Derivati arilmetilamina koji se koriste kao inhibitori triptaze
WO2001080860A3 (en) Daily treatment for erectile dysfunction using a pde5 inhibitor
TW200635925A (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
IL140468A0 (en) Benzoxazole derivatives and pharmaceutical compositions containing the same
TW200505916A (en) 7-azaindoles and the use thereof as therapeutic agents
TW200505448A (en) 5-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents
TW200503693A (en) 4-, 6- or 7-hydroxyindoles with n-oxide groups and the use thereof as therapeutic agents
CA2239053A1 (en) Diphenyl pyridyl ethane derivatives as pde iv inhibitors
GEP20094596B (en) Compositions comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction